Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose levels. There are four main types: type 1 caused by lack of insulin; type 2 caused by insulin resistance and lack of insulin; gestational occurring during pregnancy; and other types associated with other conditions. Symptoms include increased urination, thirst, hunger, and weight loss. Complications include heart disease, stroke, eye problems, kidney disease, and nerve damage. Treatment involves diet, exercise, blood glucose monitoring, medication including insulin injections, and health education.
Educational Grand Rounds: Diabetes and Lifestyle ModificationS'eclairer
Dr. Zahida Chaudhary presents a slide deck on Diabetes along with James Ellermeyer as they discuss what our society is doing to contribute to the problem and what we can do to change it in our own lives on a case by case basis.
Educational Grand Rounds: Diabetes and Lifestyle ModificationS'eclairer
Dr. Zahida Chaudhary presents a slide deck on Diabetes along with James Ellermeyer as they discuss what our society is doing to contribute to the problem and what we can do to change it in our own lives on a case by case basis.
SIGNIFICANCE
OVERVIEW
WHAT IS DIABETES?
DEFINITION
MECHANISM
PREVELANCE
EPIDEMIOLOGY
CLASSIFICATION
GESTATIONAL DIABETES
RISK FACTORS
DIAGNOSIS
COMPLICATIONS
MEDICAL TEST
MEDICAL NUTRITIONAL THERAPY
HERBS FOR DIABETES
MYTHS AND FACTS
REFERENCES
Diabetes mellitus, disorder of carbohydrate metabolism characterized by impaired ability of the body to produce or respond to insulin and thereby maintain proper levels of sugar (glucose) in the blood.
To know more about diabetes mellitus click on the below link
https://docmode.org/about/
https://docmode.org/lectures/
SIGNIFICANCE
OVERVIEW
WHAT IS DIABETES?
DEFINITION
MECHANISM
PREVELANCE
EPIDEMIOLOGY
CLASSIFICATION
GESTATIONAL DIABETES
RISK FACTORS
DIAGNOSIS
COMPLICATIONS
MEDICAL TEST
MEDICAL NUTRITIONAL THERAPY
HERBS FOR DIABETES
MYTHS AND FACTS
REFERENCES
Diabetes mellitus, disorder of carbohydrate metabolism characterized by impaired ability of the body to produce or respond to insulin and thereby maintain proper levels of sugar (glucose) in the blood.
To know more about diabetes mellitus click on the below link
https://docmode.org/about/
https://docmode.org/lectures/
Introduction to Diabetes & anti diabetic drug screening methodsAnurag Raghuvanshi
Diabetes is one of the most common life long disese now days & there are various works done in pharma. how dugs are developed & the animals used in this methodolgy is well brief in these slides.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Ppt presentation on diabetes mellitus
1. Presented By :
Dr Sangeeta Sunil Bhujbal
Lecturer
College Of Nursing,
B.J.Govt.Medical .College
Sassoon General Hospital.
Pune.(Maharashtra)
2. Diabetes mellitus is a group of
metabolic diseases characterized by
increased level of glucose in the
blood resulting from defects in
insulin, secretion , insulin action or
both.
(ADA)
4. Type-I-IDDM –
Inadequate amount of insulin are produced
by pancreas resulting in insulin deficiency &
so patient need for insulin injection to control
the blood.
Type-II-(NIDDM)
Result from decrease in the sensitivity of
the cell to insulin & a decrease in amount in
amount of insulin produced.
Gestation-DM –
Person have onset of glucose abnormality
during pregnancy.
5. ETIOLOGY
1) Type-I
A) Genetic factors- people do not inherit type I
diabetes itself, they inherit a genetic
predisposition for tendency towards developing
Type-I diabetes.
B) Immunological factor- In Type-I diabetes there
is evidence of an auto immune response. This is
an abnormal in body, responding to these tissues
as if they are foreign auto antibodies against
itself cells & against endogenous ( Internal
insulin)
C) Environmental factors- certain viruses or
toxins may precipitate the auto immune process
that leads to beta cell destruction.
6. ETIOLOGY
2.Type-II Diabetes
A) Age- ( Insulin resistance) tends to occur age
over 65 years.)
B) Obesity.
C) Family History.
D) Ethnic Group- Which are more susceptible
than blacks.
8. Type-I Pathophysiology
Due to food eaten cannot be
stored but instead remains in
the blood stain
Post pradeal (after
medication) Hyperglycemia
Due to unchecked
production by the liver
Fasting hyper Glycemia
Deficiency in production of insulin by pancreatic
beta cells
In addition the breakdown of fat occurs , resulting in
an increased production of ketone bodies. Excess
ketone resulting ketoacidosis (DKA)
10. Assessing the patient with
Diabetes
1) History –
Symptoms related to the diagnose of
DM
Results of blood glucose monitoring
Status symptoms & management of
chronic complications of DM
Use of tobacco alcohol
Life style cultural psychological &
economic factors that may affect DM
treatment.
11. Physical Examination
Blood pressure (seating, Standing)
Body Mass Index (Weight/ Height in cm x 100)
Fundo scopic examination
Foot examination
Skin examination
Neurological examination
Oral examination
12. Diagnostic Evaluation
1. Fasting plasma glucose level-above 140 mg/dl or
Random Plasma glucose level over 200 mg/dl
2. Glucose tolerance Test
3. HgbA1 (A1C)
4. Test for microalbuminurea
5. Serum creatinine level
6. Urine analysis
7. Electrocardiogram
13. Signs & Symptoms
Three Ps
1) Polyurea ( Increased urination)
2) Plydispsia ( Increased thirst)
3) Polyphagia( Increased appetite)
Other S/S
Glycosuria
Electrolyte loss
Fatigue & weakness
Tingling or numbness in handsor feet.
Skin lesion or wound that are slow to
heal.
Dry Skin
Recurrent infection.
If diabetic Ketoacidosis
Sudden weight loss
Nausea
Vomiting
Abdominal pain
Fruit order of breath
Hypertension
Even comma or death.
14. Medical Treatment
Agent Starting
Dose
Max.
Dose
Duration of
action
Freq. Metabolism
First Generation
1)Tolbutamide 0.5 mg 2-3 gm 6-12 hrs 1-3 days By liver to inactive
product
2)Tolazamide 100 mg 1.0 gm 12-24 hrs 1-2 days By liver to active &
inactive products
requiring renal route
3)Acetohexami
de
250 mg 1.5 gm 12-18 hrs 1-2 days Same tolazamide
4)Chloropropa
mide
100-250
mg
0.5gm 50 hrs 1 /day Approx 70% by liver to
less active product by
renal route imperative
Second Generation- Biguonides
1) Glyburide 2.5-
5.0mg
20 mg 10-20 hrs 1-2/days By liver to mostly insert
product
2) Glipizide 2.5-5.0
mg
40 mg 12-24 hrs 1-2 days By liver to insert
products
16. Complications
A) Acute Complications-
1) Hypoglycemia
2) Hyperglycemia may lead to
* Diabetic ketoacodosis in type-I DM
* Hyperosmolar, non ketotic syndrome
in
Type-II Diabetes
B) Chronic Complications-
1) Macrovasclar Disease
a) Coronary artery disease
b) Cerebro vascular disease
c) Peripheral vascular disease
2) Micro vascular Disease
a) Retinopathy
b) Nephropathy
c) Neuropathy
18. Nutritional
Elements
Quantity
Calories Ideal Weight x 28
Cal/ Kg
Carbohydrate 45% to 60%
Protein 0.8gm/Kg of body
weight
Fat
1)Polyunsatu
rated fat
2)Saturated
fat
3)Cholesterol
60% to 8%
10%
< 300 mg/ day
Fibre 40 gm/ day
Sodium <= 3000mg/day
19. EXERCISE
I) Benefits of Exercise
Improve Insulin Insensitivity
Lower blood glucose during & after exercise
Improves lipid profile
Improves some hypertension
Increase energy expenditure
Promotes cardiovascular fitness
Increased strength & flexibility
Improves sense of well being.
Exercise Type-Aerobic
III) Monitoring
Self monitoring of blood glucose
Urine glucose
Urine testing for ketones.
20. Health Education
Teach the client to identify clinical
manifestations & how to manage
hypoglycemia.
How to check of insulin reaction
Tell patient avoid excessive exercise
Take food soon after insulin, do not delay.
Teach the client about diet & insulin dose.
Explain the patient to carry Identification
card & sugar.
Explain about the prevention of long term
complications of diabetes & develop
positive self concept & a feeling of control.